Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Mercury Pharma International Ltd, 4045, Kingswood Road, City West Business Park, Co Dublin, Ireland
Furosemide 20mg/2ml Solution for Injection.
Furosemide 50mg/5ml Solution for Injection.
Furosemide 250mg/25ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Colourless or almost colourless sterile solution intended for parenteral administration to human beings. |
Each 1ml of solution contains 10mg of Furosemide B.P.
Excipient(s) with known effect: Sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Furosemide |
Furosemide inhibits active chloride transport in the thick ascending limb. Re-absorption of sodium, chloride from the nephron is reduced and a hypotonic or isotonic urine produced. The evidence from many experimental studies suggests that furosemide acts along the entire nephron with the exception of the distal exchange site. |
| List of Excipients |
|---|
|
Sodium Chloride B.P. |
2ml, 5ml & 25ml One point cut (OPC) amber glass ampoules, glass type 1 Ph.Eur. packed in cardboard cartons to contain 10 × 2ml or 10 × 5ml or 10 × 25ml ampoules.
Not all pack sizes may be marketed.
Mercury Pharma International Ltd, 4045, Kingswood Road, City West Business Park, Co Dublin, Ireland
PL 2848/0103
24/09/1990 / 18/06/2003
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
